Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wolfgang Landgraf
Observed names:
W Landgraf,
W. Landgraf,
WOLFGANG LANDGRAF,
Wolfgang LANDGRAF
Observed institutions:
Heidelberg University,
Sanofi (France),
Sanofi (United States),
Institut für Klinische Forschung und Entwicklung,
Sanofi (Germany),
University Hospital Carl Gustav Carus,
Technical University of Munich,
Technische Universität Dresden,
Saarland University
show all 9
ORCID:
0000-0001-5321-7164
Observed ORCID:
0000-0001-5321-7164
OpenAlex ID:
A5058274800
Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial
2008
·
Reinhard G Bretzel
, Ulrike Nuber
, et al.
·
The Lancet
·
307
Regulation of cytosolic calcium by cAMP and cGMP in freshly isolated smooth muscle cells from bovine trachea.
1988
·
J Felbel
, B Trockur
, et al.
·
Journal of Biological Chemistry
·
145
Structure and physiological role of cGMP-dependent protein kinase
1992
·
Franz Hofmann
, Wolfgang Dostmann
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
·
126
The activation of expressed cGMP‐dependent protein kinase isozymes Iα and Iβ is determined by the different amino‐termini
1991
·
Peter RUTH
, Wolfgang LANDGRAF
, et al.
·
European Journal of Biochemistry
·
101
Phosphorylation of cGMP-dependent protein kinase increases the affinity for cyclic AMP
1986
·
Wolfgang LANDGRAF
, Roger HULLIN
, et al.
·
European Journal of Biochemistry
·
82
The Emergence of Biosimilar Insulin Preparations—A Cause for Concern?
2012
·
David R. Owens
, Wolfgang Landgraf
, et al.
·
Diabetes Technology & Therapeutics
·
67
Oxidation of cysteines activates cGMP-dependent protein kinase.
1991
·
W. Landgraf
, S. Regulla
, et al.
·
Journal of Biological Chemistry
·
66
A catalytically active fragment of cGMP-dependent protein kinase. Occupation of its cGMP-binding sites does not affect its phosphotransferase activity
1987
·
Wolfgang G. HEIL
, Wolfgang LANDGRAF
, et al.
·
European Journal of Biochemistry
·
64
Recombinant Human Insulins – Clinical Efficacy and Safety in Diabetes Therapy
2016
·
Wolfgang Landgraf
, Juergen Sandow
·
touchREVIEWS in Endocrinology
·
51
PDF
Effects of insulin glargine versus metformin on glycemic variability, microvascular and beta-cell function in early type 2 diabetes
2013
·
F. Pistrosch
, C. Köhler
, et al.
·
Acta Diabetologica
·
48
PDF
Effects of cyclic GMP on the secondary structure of cyclic GMP dependent protein kinase and an analysis of the enzymes and amino-terminal domain by far-ultraviolet circular dichroism
1990
·
Wolfgang Landgraf
, Franz Hofmann
, et al.
·
Biochemistry
·
48
Patient-level meta-analysis of efficacy and hypoglycaemia in people with type 2 diabetes initiating insulin glargine 100U/mL or neutral protamine Hagedorn insulin analysed according to concomitant oral antidiabetes therapy
2016
·
David R. Owens
, Louise Traylor
, et al.
·
Diabetes Research and Clinical Practice
·
43
Efficacy and safety of basal insulin glargine 12 and 24 weeks after initiation in persons with type 2 diabetes: A pooled analysis of data from treatment arms of 15 treat-to-target randomised controlled trials
2014
·
David R. Owens
, Louise Traylor
, et al.
·
Diabetes Research and Clinical Practice
·
43
PDF
Insulin glargine compared with premixed insulin for management of insulin-naïve type 2 diabetes patients uncontrolled on oral antidiabetic drugs: the open-label, randomized GALAPAGOS study
2015
·
Pablo Aschner
, Bipin Sethi
, et al.
·
Journal of Diabetes and its Complications
·
40
PDF
Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents
2009
·
Reinhard G. Bretzel
, Michael Eckhard
, et al.
·
Diabetes Care
·
40
PDF
The amino terminus regulates binding to and activation of cGMP‐dependent protein kinase
1989
·
Wolfgang LANDGRAF
, Franz HOFMANN
·
European Journal of Biochemistry
·
38
PDF
ACE inhibition and atherogenesis
2002
·
Bernward A Schölkens
, Wolfgang Landgraf
·
Canadian Journal of Physiology and Pharmacology
·
35
Equivalent Recombinant Human Insulin Preparations and their Place in Therapy
2015
·
Juergen Sandow
, Wolfgang Landgraf
, et al.
·
touchREVIEWS in Endocrinology
·
32
PDF
Relationship Between HbA1c on Target, Risk of Silent Hypoglycemia and Glycemic Variability in Patients with Type 2 Diabetes Mellitus
2011
·
B. Engler
, C. Koehler
, et al.
·
Experimental and Clinical Endocrinology & Diabetes
·
26
Glycaemic responses in Asian and non-Asian people with type 2 diabetes initiating insulin glargine 100 units/mL: A patient-level pooled analysis of 16 randomised controlled trials
2017
·
Juliana C.N. Chan
, Pongamorn Bunnag
, et al.
·
Diabetes Research and Clinical Practice
·
24
Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%
2018
·
David R. Owens
, Wolfgang Landgraf
, et al.
·
Diabetes Obesity and Metabolism
·
23
PDF
Modulation of insulin dose titration using a hypoglycaemia‐sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin‐naïve people with type 2 diabetes
2014
·
P. D. Home
, G. B. Bolli
, et al.
·
Diabetes Obesity and Metabolism
·
22
PDF
Diastereomers of adenosine 3′,5′‐monothionophosphate (cAMP[S] antagonize the activation of cGMP‐dependent protein kinase
1985
·
Franz HOFMANN
, Hans‐Peter GENSHEIMER
, et al.
·
European Journal of Biochemistry
·
21
Fasting C‐peptide, a biomarker for hypoglycaemia risk in insulin‐naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mL
2019
·
Wolfgang Landgraf
, David R. Owens
, et al.
·
Diabetes Obesity and Metabolism
·
20
Insulin Glulisine in Pregnancy – Experience from Clinical Trials and Post-marketing Surveillance
2015
·
Zoran Doder
, Demi Vanechanos
, et al.
·
touchREVIEWS in Endocrinology
·
19
PDF
Show more works
View as search
Works count:
84
Citation count:
1,702
H-index:
22
I10-index:
32
Year
Topic
Type
